Benedict‐Tilman Berger

Also affiliated with Frankfurt Institute for Advanced Studies

Biochemistry, Genetics and Molecular BiologyMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance”.

Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2111451118

N/A

0DataRank · unranked

73 citations

Benedict‐Tilman Berger, Aziz M. Rangwala, YiTing Paung, Jessica Tom, Hannah Philipose +7 more

Controlling the Covalent Reactivity of a Kinase Inhibitor with Light

Angewandte Chemie International Edition(2021)10.1002/anie.202103767

N/A

0DataRank · unranked

46 citations

A. Chaikuad, Benedict‐Tilman Berger, Katharina Bauer, Pierre Koch, Stefan Laufer +3 more

Design of a “Two-in-One” Mutant-Selective Epidermal Growth Factor Receptor Inhibitor That Spans the Orthosteric and Allosteric Sites

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00848

N/A

0DataRank · unranked

43 citations

David E. Heppner, Ciric To, Marcel Günther, Bo Hee Shin, Jaimin K. Rana +13 more

Controlling the Covalent Reactivity of a Kinase Inhibitor with Light

Angewandte Chemie(2021)10.1002/ange.202103767

N/A

0DataRank · unranked

4 citations

A. Chaikuad, Benedict‐Tilman Berger, Katharina Bauer, Pierre Koch, Stefan Laufer +3 more

Mutation in Abl kinase with altered drug binding kinetics indicates a novel mechanism of imatinib resistance

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.28.449968

N/A

0DataRank · unranked

4 citations

Benedict‐Tilman Berger, Aziz M. Rangwala, YiTing Paung, Jessica Tom, Hannah Philipose +7 more

Resistance to kinase inhibition through shortened target engagement

Molecular & Cellular Oncology(2022)10.1080/23723556.2022.2029999

N/A

0DataRank · unranked

5 citations

Benedict‐Tilman Berger, Matthew B. Robers, Stefan Knapp, Markus A. Seeliger, Aziz M. Rangwala

Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting

eLife(2023)10.7554/elife.86189

N/A

0DataRank · unranked

10 citations

Sukrit Singh, Benedict‐Tilman Berger, Stefan Knapp, John D. Chodera, Markus A. Seeliger +1 more

Death by a Thousand Cuts – Combining Kinase Inhibitors for Selective Target Inhibition and Rational Polypharmacology

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.13.523972

N/A

0DataRank · unranked

1 citations

Sukrit Singh, Benedict‐Tilman Berger, Stefan Knapp, John D. Chodera, Markus A. Seeliger +1 more

Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase Inhibitors

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c00411

N/A

0DataRank · unranked

14 citations

Rezart Zhubi, Andreas Krämer, Marwah Karim, Do Hoang Nhu Tran, Andreas C. Joerger +12 more

Back-pocket optimization of 2-aminopyrimidine-based macrocycles leads to potent dual EPHA2/GAK kinase inhibitors with antiviral activity

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.18.580805

N/A

0DataRank · unranked

1 citations

Rezart Zhubi, Andreas Kraemer, Marwah Karim, Do Hoang Nhu Tran, Andreas C. Joerger +12 more